Zydus has priced it at Rs 2,800 per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.
Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences` antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world`s third-worst hit nation.
Zydus has priced it at Rs 2,800 per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.
Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
.png)
